The influence of fever on the pharmacokinetics of cefazolin was investigate
d in patients with acute febrile diseases. Nine patients were included in t
he study. Antibiotic serum concentrations were determined using high perfor
mance liquid chromatograpy (HPLC). An analog computer and the SIMULINK soft
ware package were used to identify the pharmacokinetic model and PCNONLIN s
oftware package to obtain the secondary parameters, In 6 patients a two-com
partment pharmacokinetic model of cefazolin was observed during fever and a
fter defervescence. In 2 patients a two-compartment model changed to a one-
compartment after defervescence, and a one-compartment model was observed i
n one patient during both periods, Cefazolin-treated patients with a two-co
mpartment model (6/9) had higher C-max, mean steady state serum concentrati
ons (C-ss), and area under the plasma concentration-time curve (AUC(0-->inf
inity)), Smaller central compartment volume (V-1), and lower clearance (Cl)
during fever. The varying distribution of antibiotics during fever probabl
y reflects different hemodynamic responses to fever.